J., Meissner, H
#EmployeeBenefits #HealthInnovation #Pharma #MadeInCanada #Wellbeing #ChronicCare #WeightManagement To view or add a comment, sign in BF Biosciences [A Subsidiary Of Ferozsons Laboratories Limited] (PSX: BFBIO) has successfully launched Zeptide (Tirzepatide) an innovative medication targeting diabetes and obesity, now introduced in a user-friendly pre-filled syringe format
At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut
When combined with hyaluronic acid, the results were even more significant surpassing either treatment used alone.[5] While human joint trials are still lacking, this is a promising area of investigation, particularly for patients dealing with both excess weight and degenerative joint conditions
Annals of Medicine, 36 (4), 315320
How do blood tests measure vitamin deficiencies